Hansoh Pharmaceutical Group Company Limited
3692
Ранг среди акций
#915
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Цена акции
$4.37
Рыночная капитализация
$26.49B
Изменение (1 день)
7.62%
Изменение (1 год)
-6.79%
Страна
CN
Торговля Hansoh Pharmaceutical Group Company Limited (3692)
Категория
Healthcare
EPS для Hansoh Pharmaceutical Group Company Limited (3692)
EPS по состоянию на June 2026 TTM: $0.16
Согласно последним финансовым отчетам и цене акций Hansoh Pharmaceutical Group Company Limited, текущий EPS компании (TTM) составляет $0.16. В конце 2023 EPS компании составлял $0.07, больше, чем показателю 2022 года, равному $0.06.
История EPS компании Hansoh Pharmaceutical Group Company Limited с 2016 по 2026
EPS на конец каждого года
| Год | EPS | Изменить |
|---|---|---|
| 2026 (TTM) | $0.16 | 59.40% |
| 2024 | $0.10 | 43.63% |
| 2023 | $0.07 | 10.66% |
| 2022 | $0.06 | -11.88% |
| 2021 | $0.07 | 7.42% |
| 2020 | $0.07 | -0.15% |
| 2019 | $0.07 | 40.63% |
| 2018 | $0.05 | 11.63% |
| 2017 | $0.04 | 14.97% |
| 2016 | $0.04 | 0.00% |
EPS для аналогичных компаний или конкурентов
| Компания | EPS | Разница в EPS | Страна |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 249.00% |
IN
|
